StockNews.AI
HIMS
CNBC
181 days

Hims & Hers to offer at-home blood draws and lab testing with new acquisition

1. Hims & Hers acquires Trybe Labs for at-home lab testing. 2. New service streamlines blood draw and testing for users. 3. Company expands services, including testing for cholesterol and testosterone. 4. Acquisition intensifies competition with Labcorp and Quest Diagnostics. 5. Stock value increased by 141% in 2025 due to positive market reception.

+8.68%Current Return
VS
+0.03%S&P 500
$61.10502/19 09:35 AM EDTEvent Start

$66.4102/20 04:00 PM EDTLatest Updated
4m saved
Insight
Article

FAQ

Why Bullish?

The acquisition enhances Hims & Hers service offerings, which may boost customer growth and revenue.

How important is it?

The article discusses a critical acquisition that will help Hims & Hers expand its market presence, directly influencing stock performance.

Why Long Term?

The integration of new services is expected to take time to solidify market position and impact profitability.

Related Companies

Related News